High-throughput colorectal cancer organoid-on-a-chip for single-organoid-analysis-based personalized drug evaluation
- 3 August 2026
- journal article
- Published by Zhejiang University Press in Bio-Design and Manufacturing
- p. 1-14
Abstract
Patient-derived colorectal cancer organoids (CRCOs) are increasingly recognized for their ability to preserve genetic, transcriptional, histological, and dKeywords
This publication has 44 references indexed in Scilit:
- The Role of CAF‐derived Vitronectin in Promoting Colorectal Cancer Progression and ImmunosuppressionAdvanced Science, 2025
- Hybrid EMT Phenotype and Cell Membrane Tension Promote Colorectal Cancer Resistance to FerroptosisAdvanced Science, 2025
- AI-enabled organoids: Construction, analysis, and applicationBioactive Materials, 2024
- Organoids revealed: morphological analysis of the profound next generation in-vitro model with artificial intelligenceBio-Design and Manufacturing, 2023
- Establishment of organoid models based on a nested array chip for fast and reproducible drug testing in colorectal cancer therapyBio-Design and Manufacturing, 2022
- Drug screening by uniform patient derived colorectal cancer hydro-organoidsBiomaterials, 2021
- Organoid Models of Tumor ImmunologyTrends in Immunology, 2020
- Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistanceJournal of Cancer Research and Clinical Oncology, 2019
- Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer PatientsCell, 2015
- Hypoxia-Inducible Factors, Stem Cells, and CancerCell, 2007